tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Wildlife

tanzania times : Latest News and In-depth Analysis
HomeWildlife
Wildlife

Dec 16, 2025

"True Savings" in Real-world Driving, Geely STARRAY EM-i achieved a GUINNESS WORLD RECORDS™ title

"True Savings" in Real-world Driving, Geely STARRAY EM-i achieved a GUINNESS WORLD RECORDS™ title

All News

JX Luxventure Signs Blockbuster USD20,000,0000 Strategic Annual Cooperation Agreement

HAIKOU,China,Jan. 15,2025-- JX Luxventure Group Inc. (Nasdaq: JXG) (the "Company"),a technology company engages in integrated tourism services,including tourism,duty-free cross-border goods,

Jan 16, 2025

Wildlife

Your Ultimate Prom Style Guide: Azazie's 2025 Atelier x Prom Collection

LOS ANGELES,Jan. 15,2025--Azazie,the leading DTC e-tailer for all things bridal and occasion wear,is thrilled to unveil its highly anticipated 2025 Atelier x Prom Collection. Designed for the modern f

Jan 16, 2025

GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability

PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa

Jan 15, 2025

Wildlife

Sands China, in Partnership with Alipay and Macau Pass, Successfully Introduced the Innovative Alipay Tap! in Macao

Simplifying payments for both domestic and international tourists MACAO,Jan. 14,2025--On Jan. 14,2025,Sands China Ltd.,Alipay and Macau Pass jointly introduced the Alipay Tap! service at Sands Resorts

Jan 15, 2025

MINISO Group Announces Completion of US$550 Million Equity Linked Securities

GUANGZHOU,China,Jan. 14,2025-- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO","MINISO Group" or the "Company"),a global value retailer offering a variety

Jan 15, 2025

Wildlife

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

Jan 15, 2025

1 ... 105 106 107 108 109 110 111 ... 116